MULAS, Olga
 Distribuzione geografica
Continente #
NA - Nord America 149
EU - Europa 49
AS - Asia 45
SA - Sud America 18
AF - Africa 1
Totale 262
Nazione #
US - Stati Uniti d'America 148
SG - Singapore 28
UA - Ucraina 22
BR - Brasile 16
CN - Cina 14
IT - Italia 14
DE - Germania 11
BD - Bangladesh 2
BE - Belgio 1
CA - Canada 1
CO - Colombia 1
SI - Slovenia 1
TR - Turchia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 262
Città #
Chandler 68
Singapore 15
Princeton 12
Jacksonville 10
Sassari 8
Wilmington 5
Ann Arbor 4
Shanghai 3
St Louis 3
Nanjing 2
Tianjin 2
Zhengzhou 2
Angra dos Reis 1
Beijing 1
Belo Horizonte 1
Brasília 1
Brussels 1
Campinas 1
Cape Town 1
Caracas 1
Catende 1
Divinópolis 1
Franco da Rocha 1
Guangzhou 1
Hangzhou 1
Jinan 1
Joinville 1
Ljubljana 1
Mariópolis 1
Montenegro 1
Norwalk 1
Palmital 1
Petrópolis 1
Pilar 1
Porto Seguro 1
Porto Torres 1
Quartu Sant'elena 1
San Francisco 1
Toronto 1
Ubá 1
Vitória da Conquista 1
Totale 163
Nome #
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib 60
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis 48
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study 46
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors 41
Favourable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib 32
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice 31
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib 12
Totale 270
Categoria #
all - tutte 1.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 4 0 2 1 2 0
2020/202136 8 0 5 0 5 0 6 0 6 6 0 0
2021/202238 2 0 2 1 0 0 0 2 2 1 13 15
2022/202396 9 14 10 14 9 9 0 9 16 0 5 1
2023/202418 5 1 0 2 3 0 4 0 0 0 1 2
2024/202556 1 2 12 7 19 15 0 0 0 0 0 0
Totale 270